Re-evaluating national screening for chronic kidney disease in the UK
New drugs have increased the potential benefits of screening but many unanswered questions remain about the best way to identify people for treatment, say Vageesh Jain and colleagues Chronic kidney disease (CKD) is a major cause of mortality and morbidity that is often diagnosed late. Data from a large medical records study found a high prevalence of undiagnosed stage 3 kidney disease (62-96%) across five high income countries.1 An estimated 11-13% of the global population have diagnosed CKD,2 and it is independently associated with increased risk of cardiovascular disease, end stage kidney d...
Source: bmj.com
